A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity

Publisher： Elsevier

ISSN： 0165-6147

Source： Trends in Pharmacological Sciences, Vol.24, Iss.7, 2003-07, pp. : 355-360

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of Lysosomal Storage Disorders: Progress with Enzyme Replacement Therapy

By Rohrbach Marianne Clarke Joe T.R.

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2697-2716

Adis International

Access to resources Recommend Favorite

Treatment options for lysosomal storage disorders: developing insights

By van Gelder Carin M Vollebregt Audrey AM Plug Iris van der Ploeg Ans T Reuser Arnold JJ

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2281-2299

Informa Healthcare

Access to resources Recommend Favorite

Pharmacological small molecules for the treatment of lysosomal storage disorders

By Smid BE Aerts JMFG Boot RG Linthorst GE Hollak CEM

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 11, 2010-11 ,pp. : 1367-1379

Informa Healthcare

Access to resources Recommend Favorite

A Chaperone-Mediated Approach to Enzyme Enhancement as a Therapeutic Option for the Lysosomal Storage Disorders

By Pastores Gregory M. Sathe Swati

Drugs in R&D, Vol. 7, Iss. 6, 2006-01 ,pp. : 339-348

Adis International

Access to resources Recommend Favorite

Enzyme therapy for the lysosomal storage disorders: principles, patents, practice and prospects

By Pastores Gregory M

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 8, 2003-08 ,pp. : 1157-1172

Informa Healthcare

Access to resources Recommend Favorite